nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—CYP2E1—prostate cancer	0.23	1	CbGaD
Dalfampridine—KCNC2—prostate gland—prostate cancer	0.0076	0.0425	CbGeAlD
Dalfampridine—KCNG1—prostate gland—prostate cancer	0.00677	0.0379	CbGeAlD
Dalfampridine—KCNV1—renal system—prostate cancer	0.00573	0.0321	CbGeAlD
Dalfampridine—KCNC4—prostate gland—prostate cancer	0.00564	0.0316	CbGeAlD
Dalfampridine—KCNQ4—prostate gland—prostate cancer	0.00542	0.0303	CbGeAlD
Dalfampridine—KCNQ5—prostate gland—prostate cancer	0.00527	0.0295	CbGeAlD
Dalfampridine—KCNG2—testis—prostate cancer	0.0052	0.0291	CbGeAlD
Dalfampridine—KCNS1—seminal vesicle—prostate cancer	0.00498	0.0279	CbGeAlD
Dalfampridine—KCNB1—epithelium—prostate cancer	0.00482	0.027	CbGeAlD
Dalfampridine—KCNC3—epithelium—prostate cancer	0.00468	0.0262	CbGeAlD
Dalfampridine—KCNS1—epithelium—prostate cancer	0.00433	0.0242	CbGeAlD
Dalfampridine—KCNA5—prostate gland—prostate cancer	0.00432	0.0242	CbGeAlD
Dalfampridine—KCNS3—prostate gland—prostate cancer	0.00423	0.0237	CbGeAlD
Dalfampridine—KCNF1—seminal vesicle—prostate cancer	0.00408	0.0229	CbGeAlD
Dalfampridine—KCNH6—prostate gland—prostate cancer	0.00386	0.0216	CbGeAlD
Dalfampridine—KCNS3—seminal vesicle—prostate cancer	0.00358	0.02	CbGeAlD
Dalfampridine—KCNV2—testis—prostate cancer	0.00351	0.0196	CbGeAlD
Dalfampridine—KCNH1—testis—prostate cancer	0.00335	0.0187	CbGeAlD
Dalfampridine—KCND3—prostate gland—prostate cancer	0.00321	0.018	CbGeAlD
Dalfampridine—KCNQ1—prostate gland—prostate cancer	0.00311	0.0174	CbGeAlD
Dalfampridine—KCNS3—epithelium—prostate cancer	0.00311	0.0174	CbGeAlD
Dalfampridine—KCNH3—testis—prostate cancer	0.00298	0.0167	CbGeAlD
Dalfampridine—KCNG1—testis—prostate cancer	0.00298	0.0167	CbGeAlD
Dalfampridine—KCNA5—renal system—prostate cancer	0.00294	0.0165	CbGeAlD
Dalfampridine—KCNH8—testis—prostate cancer	0.00289	0.0162	CbGeAlD
Dalfampridine—KCNS3—renal system—prostate cancer	0.00288	0.0161	CbGeAlD
Dalfampridine—KCNS3—urethra—prostate cancer	0.00283	0.0158	CbGeAlD
Dalfampridine—KCNC3—testis—prostate cancer	0.00281	0.0157	CbGeAlD
Dalfampridine—KCNQ1—seminal vesicle—prostate cancer	0.00263	0.0147	CbGeAlD
Dalfampridine—KCNH6—renal system—prostate cancer	0.00263	0.0147	CbGeAlD
Dalfampridine—KCNA2—testis—prostate cancer	0.0026	0.0145	CbGeAlD
Dalfampridine—KCNS1—testis—prostate cancer	0.0026	0.0145	CbGeAlD
Dalfampridine—CYP2E1—urine—prostate cancer	0.00254	0.0142	CbGeAlD
Dalfampridine—KCND1—testis—prostate cancer	0.00248	0.0139	CbGeAlD
Dalfampridine—KCNC4—testis—prostate cancer	0.00248	0.0139	CbGeAlD
Dalfampridine—KCNH7—testis—prostate cancer	0.00239	0.0134	CbGeAlD
Dalfampridine—KCNC1—testis—prostate cancer	0.00239	0.0134	CbGeAlD
Dalfampridine—KCNQ4—testis—prostate cancer	0.00239	0.0134	CbGeAlD
Dalfampridine—KCNQ1—renal system—prostate cancer	0.00212	0.0119	CbGeAlD
Dalfampridine—KCNQ1—urethra—prostate cancer	0.00208	0.0117	CbGeAlD
Dalfampridine—KCNA3—lymph node—prostate cancer	0.00198	0.0111	CbGeAlD
Dalfampridine—KCNA5—testis—prostate cancer	0.0019	0.0106	CbGeAlD
Dalfampridine—KCNA2—lymph node—prostate cancer	0.00188	0.0105	CbGeAlD
Dalfampridine—KCNS3—testis—prostate cancer	0.00186	0.0104	CbGeAlD
Dalfampridine—KCNC4—lymph node—prostate cancer	0.0018	0.0101	CbGeAlD
Dalfampridine—KCNQ2—testis—prostate cancer	0.00171	0.0096	CbGeAlD
Dalfampridine—KCNQ5—lymph node—prostate cancer	0.00168	0.00942	CbGeAlD
Dalfampridine—KCND2—testis—prostate cancer	0.00162	0.00909	CbGeAlD
Dalfampridine—KCNQ1—bone marrow—prostate cancer	0.0016	0.00897	CbGeAlD
Dalfampridine—KCND3—testis—prostate cancer	0.00142	0.00792	CbGeAlD
Dalfampridine—KCNA5—lymph node—prostate cancer	0.00138	0.00772	CbGeAlD
Dalfampridine—KCNQ1—testis—prostate cancer	0.00137	0.00767	CbGeAlD
Dalfampridine—KCNS3—lymph node—prostate cancer	0.00135	0.00756	CbGeAlD
Dalfampridine—KCNH2—prostate gland—prostate cancer	0.00119	0.00664	CbGeAlD
Dalfampridine—KCND3—lymph node—prostate cancer	0.00103	0.00574	CbGeAlD
Dalfampridine—KCNH2—seminal vesicle—prostate cancer	0.001	0.00561	CbGeAlD
Dalfampridine—KCNQ1—lymph node—prostate cancer	0.000993	0.00556	CbGeAlD
Dalfampridine—CYP2E1—prostate gland—prostate cancer	0.000913	0.00511	CbGeAlD
Dalfampridine—KCNH2—renal system—prostate cancer	0.000808	0.00452	CbGeAlD
Dalfampridine—KCNH2—urethra—prostate cancer	0.000794	0.00444	CbGeAlD
Dalfampridine—CYP2E1—seminal vesicle—prostate cancer	0.000773	0.00432	CbGeAlD
Dalfampridine—CYP2E1—renal system—prostate cancer	0.000623	0.00348	CbGeAlD
Dalfampridine—CYP2E1—urethra—prostate cancer	0.000612	0.00342	CbGeAlD
Dalfampridine—KCNH2—bone marrow—prostate cancer	0.000611	0.00342	CbGeAlD
Dalfampridine—KCNH2—testis—prostate cancer	0.000522	0.00292	CbGeAlD
Dalfampridine—Infection—Estradiol—prostate cancer	0.000424	0.00145	CcSEcCtD
Dalfampridine—Urticaria—Conjugated Estrogens—prostate cancer	0.000424	0.00145	CcSEcCtD
Dalfampridine—Angiopathy—Etoposide—prostate cancer	0.000423	0.00145	CcSEcCtD
Dalfampridine—Convulsion—Mitoxantrone—prostate cancer	0.000422	0.00145	CcSEcCtD
Dalfampridine—Immune system disorder—Etoposide—prostate cancer	0.000421	0.00144	CcSEcCtD
Dalfampridine—Mediastinal disorder—Etoposide—prostate cancer	0.00042	0.00144	CcSEcCtD
Dalfampridine—Nervous system disorder—Estradiol—prostate cancer	0.000419	0.00144	CcSEcCtD
Dalfampridine—Infestation NOS—Capecitabine—prostate cancer	0.000417	0.00143	CcSEcCtD
Dalfampridine—Infestation—Capecitabine—prostate cancer	0.000417	0.00143	CcSEcCtD
Dalfampridine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000416	0.00143	CcSEcCtD
Dalfampridine—Chest pain—Mitoxantrone—prostate cancer	0.000415	0.00142	CcSEcCtD
Dalfampridine—Skin disorder—Estradiol—prostate cancer	0.000415	0.00142	CcSEcCtD
Dalfampridine—Anxiety—Mitoxantrone—prostate cancer	0.000414	0.00142	CcSEcCtD
Dalfampridine—Rash—Ethinyl Estradiol—prostate cancer	0.000413	0.00142	CcSEcCtD
Dalfampridine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000412	0.00141	CcSEcCtD
Dalfampridine—Headache—Ethinyl Estradiol—prostate cancer	0.00041	0.00141	CcSEcCtD
Dalfampridine—Urinary tract infection—Capecitabine—prostate cancer	0.000406	0.00139	CcSEcCtD
Dalfampridine—CYP2E1—testis—prostate cancer	0.000402	0.00225	CbGeAlD
Dalfampridine—Confusional state—Mitoxantrone—prostate cancer	0.000401	0.00138	CcSEcCtD
Dalfampridine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000398	0.00136	CcSEcCtD
Dalfampridine—Hypersensitivity—Goserelin—prostate cancer	0.000397	0.00136	CcSEcCtD
Dalfampridine—Infection—Mitoxantrone—prostate cancer	0.000395	0.00136	CcSEcCtD
Dalfampridine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000393	0.00135	CcSEcCtD
Dalfampridine—Back pain—Etoposide—prostate cancer	0.000392	0.00135	CcSEcCtD
Dalfampridine—Nausea—Ethinyl Estradiol—prostate cancer	0.000389	0.00133	CcSEcCtD
Dalfampridine—Asthenia—Goserelin—prostate cancer	0.000386	0.00133	CcSEcCtD
Dalfampridine—Skin disorder—Mitoxantrone—prostate cancer	0.000386	0.00133	CcSEcCtD
Dalfampridine—Insomnia—Estradiol—prostate cancer	0.000386	0.00132	CcSEcCtD
Dalfampridine—Paraesthesia—Estradiol—prostate cancer	0.000383	0.00131	CcSEcCtD
Dalfampridine—Asthenia—Conjugated Estrogens—prostate cancer	0.000383	0.00131	CcSEcCtD
Dalfampridine—Dyspnoea—Estradiol—prostate cancer	0.000381	0.00131	CcSEcCtD
Dalfampridine—Connective tissue disorder—Docetaxel—prostate cancer	0.00038	0.0013	CcSEcCtD
Dalfampridine—KCNH2—lymph node—prostate cancer	0.000379	0.00212	CbGeAlD
Dalfampridine—Dyspepsia—Estradiol—prostate cancer	0.000376	0.00129	CcSEcCtD
Dalfampridine—Hypotension—Mitoxantrone—prostate cancer	0.000372	0.00127	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Estradiol—prostate cancer	0.000369	0.00126	CcSEcCtD
Dalfampridine—Connective tissue disorder—Capecitabine—prostate cancer	0.000368	0.00126	CcSEcCtD
Dalfampridine—Constipation—Estradiol—prostate cancer	0.000365	0.00125	CcSEcCtD
Dalfampridine—Paraesthesia—Mitoxantrone—prostate cancer	0.000357	0.00123	CcSEcCtD
Dalfampridine—Dizziness—Goserelin—prostate cancer	0.000356	0.00122	CcSEcCtD
Dalfampridine—Dyspnoea—Mitoxantrone—prostate cancer	0.000355	0.00122	CcSEcCtD
Dalfampridine—Dizziness—Conjugated Estrogens—prostate cancer	0.000353	0.00121	CcSEcCtD
Dalfampridine—Feeling abnormal—Estradiol—prostate cancer	0.000352	0.00121	CcSEcCtD
Dalfampridine—Convulsion—Etoposide—prostate cancer	0.000351	0.0012	CcSEcCtD
Dalfampridine—Angiopathy—Docetaxel—prostate cancer	0.000351	0.0012	CcSEcCtD
Dalfampridine—Dyspepsia—Mitoxantrone—prostate cancer	0.00035	0.0012	CcSEcCtD
Dalfampridine—Immune system disorder—Docetaxel—prostate cancer	0.00035	0.0012	CcSEcCtD
Dalfampridine—Mediastinal disorder—Docetaxel—prostate cancer	0.000349	0.0012	CcSEcCtD
Dalfampridine—Chest pain—Etoposide—prostate cancer	0.000345	0.00118	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000343	0.00118	CcSEcCtD
Dalfampridine—Vomiting—Goserelin—prostate cancer	0.000342	0.00117	CcSEcCtD
Dalfampridine—Constipation—Mitoxantrone—prostate cancer	0.00034	0.00117	CcSEcCtD
Dalfampridine—Angiopathy—Capecitabine—prostate cancer	0.00034	0.00117	CcSEcCtD
Dalfampridine—Rash—Goserelin—prostate cancer	0.00034	0.00116	CcSEcCtD
Dalfampridine—Dermatitis—Goserelin—prostate cancer	0.000339	0.00116	CcSEcCtD
Dalfampridine—Vomiting—Conjugated Estrogens—prostate cancer	0.000339	0.00116	CcSEcCtD
Dalfampridine—Urticaria—Estradiol—prostate cancer	0.000339	0.00116	CcSEcCtD
Dalfampridine—Mental disorder—Docetaxel—prostate cancer	0.000339	0.00116	CcSEcCtD
Dalfampridine—Immune system disorder—Capecitabine—prostate cancer	0.000338	0.00116	CcSEcCtD
Dalfampridine—Mediastinal disorder—Capecitabine—prostate cancer	0.000338	0.00116	CcSEcCtD
Dalfampridine—Nasopharyngitis—Epirubicin—prostate cancer	0.000337	0.00116	CcSEcCtD
Dalfampridine—Headache—Goserelin—prostate cancer	0.000337	0.00116	CcSEcCtD
Dalfampridine—Rash—Conjugated Estrogens—prostate cancer	0.000336	0.00115	CcSEcCtD
Dalfampridine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000336	0.00115	CcSEcCtD
Dalfampridine—Headache—Conjugated Estrogens—prostate cancer	0.000334	0.00115	CcSEcCtD
Dalfampridine—Confusional state—Etoposide—prostate cancer	0.000334	0.00114	CcSEcCtD
Dalfampridine—Anaphylactic shock—Etoposide—prostate cancer	0.000331	0.00113	CcSEcCtD
Dalfampridine—Infection—Etoposide—prostate cancer	0.000329	0.00113	CcSEcCtD
Dalfampridine—Mental disorder—Capecitabine—prostate cancer	0.000328	0.00113	CcSEcCtD
Dalfampridine—Connective tissue disorder—Prednisone—prostate cancer	0.000328	0.00113	CcSEcCtD
Dalfampridine—Feeling abnormal—Mitoxantrone—prostate cancer	0.000328	0.00112	CcSEcCtD
Dalfampridine—Back pain—Docetaxel—prostate cancer	0.000326	0.00112	CcSEcCtD
Dalfampridine—Skin disorder—Etoposide—prostate cancer	0.000321	0.0011	CcSEcCtD
Dalfampridine—Nausea—Goserelin—prostate cancer	0.00032	0.0011	CcSEcCtD
Dalfampridine—Nausea—Conjugated Estrogens—prostate cancer	0.000317	0.00109	CcSEcCtD
Dalfampridine—Urticaria—Mitoxantrone—prostate cancer	0.000316	0.00108	CcSEcCtD
Dalfampridine—Back pain—Capecitabine—prostate cancer	0.000316	0.00108	CcSEcCtD
Dalfampridine—Hypersensitivity—Estradiol—prostate cancer	0.000315	0.00108	CcSEcCtD
Dalfampridine—Nasopharyngitis—Doxorubicin—prostate cancer	0.000312	0.00107	CcSEcCtD
Dalfampridine—Hypotension—Etoposide—prostate cancer	0.000309	0.00106	CcSEcCtD
Dalfampridine—Asthenia—Estradiol—prostate cancer	0.000306	0.00105	CcSEcCtD
Dalfampridine—Tremor—Capecitabine—prostate cancer	0.000306	0.00105	CcSEcCtD
Dalfampridine—Angiopathy—Prednisone—prostate cancer	0.000303	0.00104	CcSEcCtD
Dalfampridine—Immune system disorder—Prednisone—prostate cancer	0.000302	0.00103	CcSEcCtD
Dalfampridine—Paraesthesia—Etoposide—prostate cancer	0.000297	0.00102	CcSEcCtD
Dalfampridine—Dyspnoea—Etoposide—prostate cancer	0.000295	0.00101	CcSEcCtD
Dalfampridine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000293	0.00101	CcSEcCtD
Dalfampridine—Mental disorder—Prednisone—prostate cancer	0.000292	0.001	CcSEcCtD
Dalfampridine—Convulsion—Docetaxel—prostate cancer	0.000292	0.001	CcSEcCtD
Dalfampridine—Infestation—Epirubicin—prostate cancer	0.000291	0.000997	CcSEcCtD
Dalfampridine—Infestation NOS—Epirubicin—prostate cancer	0.000291	0.000997	CcSEcCtD
Dalfampridine—Chest pain—Docetaxel—prostate cancer	0.000287	0.000984	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Etoposide—prostate cancer	0.000286	0.00098	CcSEcCtD
Dalfampridine—Asthenia—Mitoxantrone—prostate cancer	0.000285	0.000979	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000285	0.000977	CcSEcCtD
Dalfampridine—Constipation—Etoposide—prostate cancer	0.000283	0.00097	CcSEcCtD
Dalfampridine—Urinary tract infection—Epirubicin—prostate cancer	0.000283	0.00097	CcSEcCtD
Dalfampridine—Dizziness—Estradiol—prostate cancer	0.000282	0.000968	CcSEcCtD
Dalfampridine—Chest pain—Capecitabine—prostate cancer	0.000278	0.000953	CcSEcCtD
Dalfampridine—Confusional state—Docetaxel—prostate cancer	0.000277	0.000951	CcSEcCtD
Dalfampridine—Anxiety—Capecitabine—prostate cancer	0.000277	0.000949	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000276	0.000946	CcSEcCtD
Dalfampridine—Anaphylactic shock—Docetaxel—prostate cancer	0.000275	0.000943	CcSEcCtD
Dalfampridine—Infection—Docetaxel—prostate cancer	0.000273	0.000937	CcSEcCtD
Dalfampridine—Feeling abnormal—Etoposide—prostate cancer	0.000273	0.000935	CcSEcCtD
Dalfampridine—Vomiting—Estradiol—prostate cancer	0.000271	0.000931	CcSEcCtD
Dalfampridine—Nervous system disorder—Docetaxel—prostate cancer	0.00027	0.000925	CcSEcCtD
Dalfampridine—Rash—Estradiol—prostate cancer	0.000269	0.000923	CcSEcCtD
Dalfampridine—Infestation NOS—Doxorubicin—prostate cancer	0.000269	0.000923	CcSEcCtD
Dalfampridine—Infestation—Doxorubicin—prostate cancer	0.000269	0.000923	CcSEcCtD
Dalfampridine—Dermatitis—Estradiol—prostate cancer	0.000269	0.000922	CcSEcCtD
Dalfampridine—Confusional state—Capecitabine—prostate cancer	0.000268	0.000921	CcSEcCtD
Dalfampridine—Headache—Estradiol—prostate cancer	0.000267	0.000917	CcSEcCtD
Dalfampridine—Skin disorder—Docetaxel—prostate cancer	0.000267	0.000916	CcSEcCtD
Dalfampridine—Angioedema—Prednisone—prostate cancer	0.000266	0.000911	CcSEcCtD
Dalfampridine—Infection—Capecitabine—prostate cancer	0.000265	0.000907	CcSEcCtD
Dalfampridine—Urticaria—Etoposide—prostate cancer	0.000263	0.000902	CcSEcCtD
Dalfampridine—Urinary tract infection—Doxorubicin—prostate cancer	0.000262	0.000897	CcSEcCtD
Dalfampridine—Nervous system disorder—Capecitabine—prostate cancer	0.000261	0.000895	CcSEcCtD
Dalfampridine—Skin disorder—Capecitabine—prostate cancer	0.000259	0.000887	CcSEcCtD
Dalfampridine—Hypotension—Docetaxel—prostate cancer	0.000257	0.000881	CcSEcCtD
Dalfampridine—Connective tissue disorder—Epirubicin—prostate cancer	0.000257	0.00088	CcSEcCtD
Dalfampridine—Nausea—Estradiol—prostate cancer	0.000254	0.00087	CcSEcCtD
Dalfampridine—Vomiting—Mitoxantrone—prostate cancer	0.000253	0.000867	CcSEcCtD
Dalfampridine—Convulsion—Prednisone—prostate cancer	0.000252	0.000863	CcSEcCtD
Dalfampridine—Rash—Mitoxantrone—prostate cancer	0.000251	0.00086	CcSEcCtD
Dalfampridine—Dermatitis—Mitoxantrone—prostate cancer	0.000251	0.000859	CcSEcCtD
Dalfampridine—Headache—Mitoxantrone—prostate cancer	0.000249	0.000855	CcSEcCtD
Dalfampridine—Hypotension—Capecitabine—prostate cancer	0.000249	0.000853	CcSEcCtD
Dalfampridine—Insomnia—Docetaxel—prostate cancer	0.000249	0.000853	CcSEcCtD
Dalfampridine—Paraesthesia—Docetaxel—prostate cancer	0.000247	0.000847	CcSEcCtD
Dalfampridine—Anxiety—Prednisone—prostate cancer	0.000247	0.000846	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000246	0.000843	CcSEcCtD
Dalfampridine—Dyspnoea—Docetaxel—prostate cancer	0.000245	0.000841	CcSEcCtD
Dalfampridine—Hypersensitivity—Etoposide—prostate cancer	0.000244	0.000836	CcSEcCtD
Dalfampridine—Dyspepsia—Docetaxel—prostate cancer	0.000242	0.00083	CcSEcCtD
Dalfampridine—Insomnia—Capecitabine—prostate cancer	0.000241	0.000826	CcSEcCtD
Dalfampridine—Paraesthesia—Capecitabine—prostate cancer	0.000239	0.00082	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000237	0.000814	CcSEcCtD
Dalfampridine—Asthenia—Etoposide—prostate cancer	0.000237	0.000814	CcSEcCtD
Dalfampridine—Connective tissue disorder—Doxorubicin—prostate cancer	0.000237	0.000814	CcSEcCtD
Dalfampridine—Dyspnoea—Capecitabine—prostate cancer	0.000237	0.000814	CcSEcCtD
Dalfampridine—Anaphylactic shock—Prednisone—prostate cancer	0.000237	0.000813	CcSEcCtD
Dalfampridine—Angiopathy—Epirubicin—prostate cancer	0.000237	0.000812	CcSEcCtD
Dalfampridine—Nausea—Mitoxantrone—prostate cancer	0.000236	0.00081	CcSEcCtD
Dalfampridine—Immune system disorder—Epirubicin—prostate cancer	0.000236	0.000809	CcSEcCtD
Dalfampridine—Infection—Prednisone—prostate cancer	0.000236	0.000808	CcSEcCtD
Dalfampridine—Mediastinal disorder—Epirubicin—prostate cancer	0.000235	0.000807	CcSEcCtD
Dalfampridine—Constipation—Docetaxel—prostate cancer	0.000235	0.000807	CcSEcCtD
Dalfampridine—Dyspepsia—Capecitabine—prostate cancer	0.000234	0.000804	CcSEcCtD
Dalfampridine—Nervous system disorder—Prednisone—prostate cancer	0.000233	0.000798	CcSEcCtD
Dalfampridine—Skin disorder—Prednisone—prostate cancer	0.00023	0.00079	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Capecitabine—prostate cancer	0.00023	0.000788	CcSEcCtD
Dalfampridine—Mental disorder—Epirubicin—prostate cancer	0.000229	0.000784	CcSEcCtD
Dalfampridine—Constipation—Capecitabine—prostate cancer	0.000228	0.000781	CcSEcCtD
Dalfampridine—Feeling abnormal—Docetaxel—prostate cancer	0.000227	0.000777	CcSEcCtD
Dalfampridine—Back pain—Epirubicin—prostate cancer	0.00022	0.000754	CcSEcCtD
Dalfampridine—Feeling abnormal—Capecitabine—prostate cancer	0.000219	0.000752	CcSEcCtD
Dalfampridine—Angiopathy—Doxorubicin—prostate cancer	0.000219	0.000752	CcSEcCtD
Dalfampridine—Dizziness—Etoposide—prostate cancer	0.000219	0.00075	CcSEcCtD
Dalfampridine—Immune system disorder—Doxorubicin—prostate cancer	0.000218	0.000748	CcSEcCtD
Dalfampridine—Mediastinal disorder—Doxorubicin—prostate cancer	0.000218	0.000747	CcSEcCtD
Dalfampridine—Insomnia—Prednisone—prostate cancer	0.000215	0.000736	CcSEcCtD
Dalfampridine—Paraesthesia—Prednisone—prostate cancer	0.000213	0.00073	CcSEcCtD
Dalfampridine—Mental disorder—Doxorubicin—prostate cancer	0.000212	0.000726	CcSEcCtD
Dalfampridine—Urticaria—Capecitabine—prostate cancer	0.000212	0.000725	CcSEcCtD
Dalfampridine—Vomiting—Etoposide—prostate cancer	0.00021	0.000722	CcSEcCtD
Dalfampridine—Dyspepsia—Prednisone—prostate cancer	0.000209	0.000716	CcSEcCtD
Dalfampridine—Rash—Etoposide—prostate cancer	0.000209	0.000716	CcSEcCtD
Dalfampridine—Dermatitis—Etoposide—prostate cancer	0.000208	0.000715	CcSEcCtD
Dalfampridine—Headache—Etoposide—prostate cancer	0.000207	0.000711	CcSEcCtD
Dalfampridine—Back pain—Doxorubicin—prostate cancer	0.000203	0.000698	CcSEcCtD
Dalfampridine—Constipation—Prednisone—prostate cancer	0.000203	0.000696	CcSEcCtD
Dalfampridine—Hypersensitivity—Docetaxel—prostate cancer	0.000203	0.000695	CcSEcCtD
Dalfampridine—Asthenia—Docetaxel—prostate cancer	0.000197	0.000677	CcSEcCtD
Dalfampridine—Convulsion—Epirubicin—prostate cancer	0.000197	0.000675	CcSEcCtD
Dalfampridine—Nausea—Etoposide—prostate cancer	0.000197	0.000674	CcSEcCtD
Dalfampridine—Hypersensitivity—Capecitabine—prostate cancer	0.000196	0.000673	CcSEcCtD
Dalfampridine—Feeling abnormal—Prednisone—prostate cancer	0.000195	0.00067	CcSEcCtD
Dalfampridine—Chest pain—Epirubicin—prostate cancer	0.000193	0.000664	CcSEcCtD
Dalfampridine—Anxiety—Epirubicin—prostate cancer	0.000193	0.000661	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000192	0.000659	CcSEcCtD
Dalfampridine—Asthenia—Capecitabine—prostate cancer	0.000191	0.000655	CcSEcCtD
Dalfampridine—Urticaria—Prednisone—prostate cancer	0.000188	0.000646	CcSEcCtD
Dalfampridine—Confusional state—Epirubicin—prostate cancer	0.000187	0.000641	CcSEcCtD
Dalfampridine—Anaphylactic shock—Epirubicin—prostate cancer	0.000185	0.000636	CcSEcCtD
Dalfampridine—Infection—Epirubicin—prostate cancer	0.000184	0.000632	CcSEcCtD
Dalfampridine—Convulsion—Doxorubicin—prostate cancer	0.000182	0.000625	CcSEcCtD
Dalfampridine—Nervous system disorder—Epirubicin—prostate cancer	0.000182	0.000624	CcSEcCtD
Dalfampridine—Dizziness—Docetaxel—prostate cancer	0.000182	0.000624	CcSEcCtD
Dalfampridine—Skin disorder—Epirubicin—prostate cancer	0.00018	0.000618	CcSEcCtD
Dalfampridine—Chest pain—Doxorubicin—prostate cancer	0.000179	0.000614	CcSEcCtD
Dalfampridine—Anxiety—Doxorubicin—prostate cancer	0.000178	0.000612	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000178	0.00061	CcSEcCtD
Dalfampridine—Dizziness—Capecitabine—prostate cancer	0.000176	0.000604	CcSEcCtD
Dalfampridine—Vomiting—Docetaxel—prostate cancer	0.000175	0.0006	CcSEcCtD
Dalfampridine—Hypersensitivity—Prednisone—prostate cancer	0.000175	0.000599	CcSEcCtD
Dalfampridine—Rash—Docetaxel—prostate cancer	0.000173	0.000595	CcSEcCtD
Dalfampridine—Hypotension—Epirubicin—prostate cancer	0.000173	0.000594	CcSEcCtD
Dalfampridine—Dermatitis—Docetaxel—prostate cancer	0.000173	0.000594	CcSEcCtD
Dalfampridine—Confusional state—Doxorubicin—prostate cancer	0.000173	0.000593	CcSEcCtD
Dalfampridine—Headache—Docetaxel—prostate cancer	0.000172	0.000591	CcSEcCtD
Dalfampridine—Anaphylactic shock—Doxorubicin—prostate cancer	0.000172	0.000589	CcSEcCtD
Dalfampridine—Infection—Doxorubicin—prostate cancer	0.000171	0.000585	CcSEcCtD
Dalfampridine—Asthenia—Prednisone—prostate cancer	0.00017	0.000584	CcSEcCtD
Dalfampridine—Vomiting—Capecitabine—prostate cancer	0.000169	0.000581	CcSEcCtD
Dalfampridine—Nervous system disorder—Doxorubicin—prostate cancer	0.000168	0.000577	CcSEcCtD
Dalfampridine—Rash—Capecitabine—prostate cancer	0.000168	0.000576	CcSEcCtD
Dalfampridine—Insomnia—Epirubicin—prostate cancer	0.000168	0.000575	CcSEcCtD
Dalfampridine—Dermatitis—Capecitabine—prostate cancer	0.000168	0.000575	CcSEcCtD
Dalfampridine—Headache—Capecitabine—prostate cancer	0.000167	0.000572	CcSEcCtD
Dalfampridine—Skin disorder—Doxorubicin—prostate cancer	0.000167	0.000572	CcSEcCtD
Dalfampridine—Paraesthesia—Epirubicin—prostate cancer	0.000167	0.000571	CcSEcCtD
Dalfampridine—Dyspnoea—Epirubicin—prostate cancer	0.000165	0.000567	CcSEcCtD
Dalfampridine—Nausea—Docetaxel—prostate cancer	0.000163	0.00056	CcSEcCtD
Dalfampridine—Dyspepsia—Epirubicin—prostate cancer	0.000163	0.00056	CcSEcCtD
Dalfampridine—Hypotension—Doxorubicin—prostate cancer	0.00016	0.00055	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Epirubicin—prostate cancer	0.00016	0.000549	CcSEcCtD
Dalfampridine—Constipation—Epirubicin—prostate cancer	0.000159	0.000544	CcSEcCtD
Dalfampridine—Nausea—Capecitabine—prostate cancer	0.000158	0.000542	CcSEcCtD
Dalfampridine—Dizziness—Prednisone—prostate cancer	0.000157	0.000538	CcSEcCtD
Dalfampridine—Insomnia—Doxorubicin—prostate cancer	0.000155	0.000532	CcSEcCtD
Dalfampridine—Paraesthesia—Doxorubicin—prostate cancer	0.000154	0.000529	CcSEcCtD
Dalfampridine—Dyspnoea—Doxorubicin—prostate cancer	0.000153	0.000525	CcSEcCtD
Dalfampridine—Feeling abnormal—Epirubicin—prostate cancer	0.000153	0.000524	CcSEcCtD
Dalfampridine—Dyspepsia—Doxorubicin—prostate cancer	0.000151	0.000518	CcSEcCtD
Dalfampridine—Vomiting—Prednisone—prostate cancer	0.000151	0.000517	CcSEcCtD
Dalfampridine—Rash—Prednisone—prostate cancer	0.00015	0.000513	CcSEcCtD
Dalfampridine—Dermatitis—Prednisone—prostate cancer	0.000149	0.000512	CcSEcCtD
Dalfampridine—Headache—Prednisone—prostate cancer	0.000149	0.00051	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000148	0.000508	CcSEcCtD
Dalfampridine—Urticaria—Epirubicin—prostate cancer	0.000147	0.000505	CcSEcCtD
Dalfampridine—Constipation—Doxorubicin—prostate cancer	0.000147	0.000503	CcSEcCtD
Dalfampridine—Feeling abnormal—Doxorubicin—prostate cancer	0.000141	0.000485	CcSEcCtD
Dalfampridine—Nausea—Prednisone—prostate cancer	0.000141	0.000483	CcSEcCtD
Dalfampridine—Hypersensitivity—Epirubicin—prostate cancer	0.000137	0.000469	CcSEcCtD
Dalfampridine—Urticaria—Doxorubicin—prostate cancer	0.000136	0.000468	CcSEcCtD
Dalfampridine—Asthenia—Epirubicin—prostate cancer	0.000133	0.000456	CcSEcCtD
Dalfampridine—Hypersensitivity—Doxorubicin—prostate cancer	0.000126	0.000434	CcSEcCtD
Dalfampridine—Asthenia—Doxorubicin—prostate cancer	0.000123	0.000422	CcSEcCtD
Dalfampridine—Dizziness—Epirubicin—prostate cancer	0.000123	0.000421	CcSEcCtD
Dalfampridine—Vomiting—Epirubicin—prostate cancer	0.000118	0.000404	CcSEcCtD
Dalfampridine—Rash—Epirubicin—prostate cancer	0.000117	0.000401	CcSEcCtD
Dalfampridine—Dermatitis—Epirubicin—prostate cancer	0.000117	0.000401	CcSEcCtD
Dalfampridine—Headache—Epirubicin—prostate cancer	0.000116	0.000399	CcSEcCtD
Dalfampridine—Dizziness—Doxorubicin—prostate cancer	0.000113	0.000389	CcSEcCtD
Dalfampridine—Nausea—Epirubicin—prostate cancer	0.00011	0.000378	CcSEcCtD
Dalfampridine—Vomiting—Doxorubicin—prostate cancer	0.000109	0.000374	CcSEcCtD
Dalfampridine—Rash—Doxorubicin—prostate cancer	0.000108	0.000371	CcSEcCtD
Dalfampridine—Dermatitis—Doxorubicin—prostate cancer	0.000108	0.000371	CcSEcCtD
Dalfampridine—Headache—Doxorubicin—prostate cancer	0.000108	0.000369	CcSEcCtD
Dalfampridine—Nausea—Doxorubicin—prostate cancer	0.000102	0.00035	CcSEcCtD
Dalfampridine—CYP2E1—Biological oxidations—CYP3A4—prostate cancer	3.25e-05	0.000108	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—RXRA—prostate cancer	3.23e-05	0.000108	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ITPR1—prostate cancer	3.22e-05	0.000107	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ITPR1—prostate cancer	3.22e-05	0.000107	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ITPR1—prostate cancer	3.22e-05	0.000107	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP3A4—prostate cancer	3.2e-05	0.000107	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP2—prostate cancer	3.2e-05	0.000107	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP2—prostate cancer	3.2e-05	0.000107	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAP2K1—prostate cancer	3.2e-05	0.000107	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAP2K1—prostate cancer	3.2e-05	0.000107	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP1B1—prostate cancer	3.19e-05	0.000106	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CASP3—prostate cancer	3.19e-05	0.000106	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP1B1—prostate cancer	3.15e-05	0.000105	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—COMT—prostate cancer	3.12e-05	0.000104	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—SRC—prostate cancer	3.11e-05	0.000104	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—SRC—prostate cancer	3.11e-05	0.000104	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTP1—prostate cancer	3.1e-05	0.000103	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GGT1—prostate cancer	3.09e-05	0.000103	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	3.08e-05	0.000103	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ITPR1—prostate cancer	3.05e-05	0.000102	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—NCOA1—prostate cancer	3.05e-05	0.000102	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—FGF2—prostate cancer	3.04e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—FGF2—prostate cancer	3.04e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TYMS—prostate cancer	3.04e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TYMS—prostate cancer	3.04e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TYMS—prostate cancer	3.04e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—prostate cancer	3.03e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—prostate cancer	3.03e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTM1—prostate cancer	3.01e-05	0.0001	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTM1—prostate cancer	3.01e-05	0.0001	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTM1—prostate cancer	3.01e-05	0.0001	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP19A1—prostate cancer	3e-05	0.0001	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP19A1—prostate cancer	2.96e-05	9.87e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—LPL—prostate cancer	2.95e-05	9.84e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—LPL—prostate cancer	2.95e-05	9.84e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—LPL—prostate cancer	2.95e-05	9.84e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—JAK2—prostate cancer	2.92e-05	9.73e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—JAK2—prostate cancer	2.92e-05	9.73e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—RXRA—prostate cancer	2.9e-05	9.66e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TYMS—prostate cancer	2.88e-05	9.61e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—EP300—prostate cancer	2.86e-05	9.53e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTM1—prostate cancer	2.85e-05	9.5e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP1A1—prostate cancer	2.85e-05	9.5e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP1A1—prostate cancer	2.85e-05	9.5e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP1A1—prostate cancer	2.85e-05	9.5e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ERCC2—prostate cancer	2.83e-05	9.42e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ERCC2—prostate cancer	2.83e-05	9.42e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ERCC2—prostate cancer	2.83e-05	9.42e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ERBB2—prostate cancer	2.81e-05	9.36e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ERBB2—prostate cancer	2.81e-05	9.36e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—LPL—prostate cancer	2.8e-05	9.32e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—COMT—prostate cancer	2.79e-05	9.31e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTP1—prostate cancer	2.78e-05	9.26e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—COMT—prostate cancer	2.75e-05	9.18e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTP1—prostate cancer	2.74e-05	9.14e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—EGFR—prostate cancer	2.73e-05	9.09e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—EGFR—prostate cancer	2.73e-05	9.09e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—prostate cancer	2.71e-05	9.03e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP1A1—prostate cancer	2.7e-05	9.01e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ERCC2—prostate cancer	2.68e-05	8.93e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—MTHFR—prostate cancer	2.66e-05	8.86e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—MTHFR—prostate cancer	2.66e-05	8.86e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—MTHFR—prostate cancer	2.66e-05	8.86e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARA—prostate cancer	2.61e-05	8.69e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARA—prostate cancer	2.61e-05	8.69e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARA—prostate cancer	2.61e-05	8.69e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KRAS—prostate cancer	2.58e-05	8.59e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KRAS—prostate cancer	2.58e-05	8.59e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTM1—prostate cancer	2.55e-05	8.51e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTM1—prostate cancer	2.52e-05	8.4e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MTHFR—prostate cancer	2.52e-05	8.4e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARA—prostate cancer	2.47e-05	8.24e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CTNNB1—prostate cancer	2.46e-05	8.19e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CTNNB1—prostate cancer	2.46e-05	8.19e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CAV1—prostate cancer	2.45e-05	8.17e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CAV1—prostate cancer	2.45e-05	8.17e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CAV1—prostate cancer	2.45e-05	8.17e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP1A1—prostate cancer	2.42e-05	8.07e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—prostate cancer	2.41e-05	8.03e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—prostate cancer	2.41e-05	8.03e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HAO1—prostate cancer	2.39e-05	7.96e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP1A1—prostate cancer	2.39e-05	7.96e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CAV1—prostate cancer	2.32e-05	7.74e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EP300—prostate cancer	2.28e-05	7.61e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EP300—prostate cancer	2.28e-05	7.61e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—MDM2—prostate cancer	2.24e-05	7.47e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CG—prostate cancer	2.23e-05	7.44e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CG—prostate cancer	2.23e-05	7.44e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CG—prostate cancer	2.23e-05	7.44e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SRC—prostate cancer	2.22e-05	7.4e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—SRC—prostate cancer	2.22e-05	7.4e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—prostate cancer	2.16e-05	7.21e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—prostate cancer	2.16e-05	7.21e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—STAT3—prostate cancer	2.14e-05	7.14e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—STAT3—prostate cancer	2.14e-05	7.14e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CG—prostate cancer	2.12e-05	7.05e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—INS—prostate cancer	2.11e-05	7.04e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—INS—prostate cancer	2.11e-05	7.04e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—INS—prostate cancer	2.11e-05	7.04e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6—prostate cancer	2.1e-05	6.99e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6—prostate cancer	2.1e-05	6.99e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CREBBP—prostate cancer	2.07e-05	6.9e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CREBBP—prostate cancer	2.07e-05	6.9e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CREBBP—prostate cancer	2.07e-05	6.9e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—INS—prostate cancer	2e-05	6.68e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TGFB1—prostate cancer	1.98e-05	6.62e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TGFB1—prostate cancer	1.98e-05	6.62e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CD—prostate cancer	1.96e-05	6.54e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CD—prostate cancer	1.96e-05	6.54e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CD—prostate cancer	1.96e-05	6.54e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CREBBP—prostate cancer	1.96e-05	6.54e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TST—prostate cancer	1.95e-05	6.49e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GRHL1—prostate cancer	1.95e-05	6.49e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PSAT1—prostate cancer	1.95e-05	6.49e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ADI1—prostate cancer	1.95e-05	6.49e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CSAD—prostate cancer	1.95e-05	6.49e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CBR1—prostate cancer	1.95e-05	6.49e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EGFR—prostate cancer	1.95e-05	6.49e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EGFR—prostate cancer	1.95e-05	6.49e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6—prostate cancer	1.87e-05	6.24e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CD—prostate cancer	1.86e-05	6.2e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NOS3—prostate cancer	1.85e-05	6.18e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NOS3—prostate cancer	1.85e-05	6.18e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NOS3—prostate cancer	1.85e-05	6.18e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KRAS—prostate cancer	1.84e-05	6.13e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KRAS—prostate cancer	1.84e-05	6.13e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UGT2B17—prostate cancer	1.81e-05	6.04e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UGT2B15—prostate cancer	1.81e-05	6.04e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GRHPR—prostate cancer	1.81e-05	6.04e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CKMT2—prostate cancer	1.81e-05	6.04e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NOS3—prostate cancer	1.76e-05	5.86e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CB—prostate cancer	1.71e-05	5.7e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CB—prostate cancer	1.71e-05	5.7e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CB—prostate cancer	1.71e-05	5.7e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NAGLU—prostate cancer	1.7e-05	5.67e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTM3—prostate cancer	1.7e-05	5.67e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AOX1—prostate cancer	1.7e-05	5.67e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SULT2B1—prostate cancer	1.7e-05	5.67e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—RFK—prostate cancer	1.7e-05	5.67e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PGAM2—prostate cancer	1.7e-05	5.67e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MBTPS1—prostate cancer	1.7e-05	5.67e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—prostate cancer	1.69e-05	5.65e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—prostate cancer	1.69e-05	5.65e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—prostate cancer	1.69e-05	5.65e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CB—prostate cancer	1.62e-05	5.4e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AMACR—prostate cancer	1.61e-05	5.38e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP3A43—prostate cancer	1.61e-05	5.38e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SRD5A2—prostate cancer	1.61e-05	5.38e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NAT1—prostate cancer	1.61e-05	5.38e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—DEGS1—prostate cancer	1.61e-05	5.38e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—prostate cancer	1.61e-05	5.36e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HSD17B1—prostate cancer	1.54e-05	5.13e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6—prostate cancer	1.5e-05	4.99e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6—prostate cancer	1.5e-05	4.99e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTEN—prostate cancer	1.48e-05	4.93e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTEN—prostate cancer	1.48e-05	4.93e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTEN—prostate cancer	1.48e-05	4.93e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—EP300—prostate cancer	1.41e-05	4.7e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—EP300—prostate cancer	1.41e-05	4.7e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—EP300—prostate cancer	1.41e-05	4.7e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTEN—prostate cancer	1.4e-05	4.67e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—prostate cancer	1.38e-05	4.6e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—prostate cancer	1.38e-05	4.6e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HPGD—prostate cancer	1.37e-05	4.57e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—B4GALT4—prostate cancer	1.37e-05	4.57e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—EP300—prostate cancer	1.34e-05	4.45e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TNFRSF21—prostate cancer	1.29e-05	4.3e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP7B1—prostate cancer	1.26e-05	4.18e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTAP—prostate cancer	1.26e-05	4.18e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SULT1E1—prostate cancer	1.22e-05	4.08e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SRD5A1—prostate cancer	1.22e-05	4.08e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ACSL4—prostate cancer	1.17e-05	3.89e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HSD17B3—prostate cancer	1.17e-05	3.89e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UMPS—prostate cancer	1.12e-05	3.73e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ARG2—prostate cancer	1.12e-05	3.73e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PHGDH—prostate cancer	1.12e-05	3.73e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LDHB—prostate cancer	1.1e-05	3.66e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP3A5—prostate cancer	1.08e-05	3.59e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CA—prostate cancer	1.04e-05	3.48e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CA—prostate cancer	1.04e-05	3.48e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CA—prostate cancer	1.04e-05	3.48e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PDHA1—prostate cancer	1.04e-05	3.47e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UCP3—prostate cancer	1.04e-05	3.47e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TCN2—prostate cancer	1.04e-05	3.47e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA3—prostate cancer	1.04e-05	3.47e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC22A3—prostate cancer	9.92e-06	3.31e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HSD3B1—prostate cancer	9.92e-06	3.31e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CA—prostate cancer	9.88e-06	3.29e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA4—prostate cancer	9.51e-06	3.17e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TBXAS1—prostate cancer	9.51e-06	3.17e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA2—prostate cancer	9.27e-06	3.09e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCG5—prostate cancer	9.16e-06	3.05e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SULT1A1—prostate cancer	9.16e-06	3.05e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA1—prostate cancer	8.94e-06	2.98e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTO1—prostate cancer	8.84e-06	2.95e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NAT2—prostate cancer	8.84e-06	2.95e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HSD3B2—prostate cancer	8.84e-06	2.95e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—prostate cancer	8.52e-06	2.84e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—prostate cancer	8.52e-06	2.84e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—prostate cancer	8.52e-06	2.84e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLCB2—prostate cancer	8.48e-06	2.83e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LRP2—prostate cancer	8.48e-06	2.83e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP2C18—prostate cancer	8.48e-06	2.83e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—P4HB—prostate cancer	8.31e-06	2.77e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC22A1—prostate cancer	8.09e-06	2.7e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—prostate cancer	8.07e-06	2.69e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SULT2A1—prostate cancer	7.88e-06	2.63e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MED12—prostate cancer	7.75e-06	2.58e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GNG5—prostate cancer	7.69e-06	2.56e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NCOA3—prostate cancer	7.41e-06	2.47e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HPGDS—prostate cancer	7.07e-06	2.36e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP2C19—prostate cancer	7.02e-06	2.34e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTT1—prostate cancer	6.86e-06	2.29e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ACHE—prostate cancer	6.86e-06	2.29e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP2A6—prostate cancer	6.78e-06	2.26e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKR1C3—prostate cancer	6.59e-06	2.2e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PRKACB—prostate cancer	6.56e-06	2.19e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP17A1—prostate cancer	6.49e-06	2.16e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NCOA2—prostate cancer	6.18e-06	2.06e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC5A5—prostate cancer	5.9e-06	1.97e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NQO1—prostate cancer	5.7e-06	1.9e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TH—prostate cancer	5.62e-06	1.87e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP3A4—prostate cancer	5.56e-06	1.85e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP1B1—prostate cancer	5.46e-06	1.82e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GGT1—prostate cancer	5.29e-06	1.76e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NCOA1—prostate cancer	5.21e-06	1.74e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP19A1—prostate cancer	5.14e-06	1.71e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—RXRA—prostate cancer	4.96e-06	1.65e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—COMT—prostate cancer	4.78e-06	1.59e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTP1—prostate cancer	4.75e-06	1.58e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ITPR1—prostate cancer	4.68e-06	1.56e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TYMS—prostate cancer	4.42e-06	1.47e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTM1—prostate cancer	4.37e-06	1.46e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LPL—prostate cancer	4.29e-06	1.43e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP1A1—prostate cancer	4.14e-06	1.38e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ERCC2—prostate cancer	4.11e-06	1.37e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTHFR—prostate cancer	3.86e-06	1.29e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARA—prostate cancer	3.79e-06	1.26e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CAV1—prostate cancer	3.56e-06	1.19e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CG—prostate cancer	3.24e-06	1.08e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—INS—prostate cancer	3.07e-06	1.02e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CREBBP—prostate cancer	3.01e-06	1e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CD—prostate cancer	2.85e-06	9.5e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NOS3—prostate cancer	2.69e-06	8.97e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CB—prostate cancer	2.48e-06	8.28e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—prostate cancer	2.46e-06	8.21e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTEN—prostate cancer	2.15e-06	7.16e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—EP300—prostate cancer	2.05e-06	6.83e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CA—prostate cancer	1.51e-06	5.05e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—prostate cancer	1.24e-06	4.12e-06	CbGpPWpGaD
